• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在模拟缺血条件下 ENT4 对 AC16 人心肌细胞中腺苷摄取的贡献及其在心脏保护中的潜在作用。

Contribution of ENT4 to adenosine uptake in AC16 human cardiomyocytes under simulated ischemic conditions and its potential role in cardioprotection.

机构信息

School of Science and Technology, The Hong Kong Metropolitan University, Hong Kong, Hong Kong.

Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, Hong Kong.

出版信息

Mol Biol Rep. 2022 Nov;49(11):11201-11208. doi: 10.1007/s11033-022-07902-3. Epub 2022 Sep 15.

DOI:10.1007/s11033-022-07902-3
PMID:36107375
Abstract

BACKGROUND

Nucleoside transporters are crucial in regulating the functions of adenosine. This study investigated the contribution of equilibrative nucleoside transporter (ENT) type 4 to adenosine transport in cardiomyocytes under simulated ischemic conditions and whether the inhibition of ENT4 could protect cardiomyocytes against ischemia-reperfusion injury.

METHODS

AC16 human cardiomyocytes were used to create a model to simulate ischemia/reperfusion injury. ENT4 activity was inhibited by decynium-22 or specific siRNA against ENT4. The protein expressions of nucleoside transporters were measured by western blot analysis. The transport activity was studied by [?H]adenosine uptake. The cell injury was studied by biochemical assays.

RESULTS

The [?H]adenosine uptake in AC16 cells was predominantly mediated by ENTs. ENT1 to ENT4 were present in AC16 cells and their protein expression levels were comparable in normal and ischemic conditions. Decynium-22 or siRNA against ENT4 did not affect the adenosine uptake in AC16 cells under normal conditions but could inhibit the adenosine uptake in AC16 cells by 28% under ischemic conditions. In addition, the cell viability and lactate dehydrogenase release of AC16 cells under ischemia conditions could be reduced by decynium-22 or siRNA against ENT4.

CONCLUSION

The cell culture model has suggested that ENT4 may play a role in adenosine transport in cardiomyocytes under ischemic conditions. Inhibition or downregulation of ENT4 may be a potential approach for cardioprotection but this notion should be further validated using animal model.

摘要

背景

核苷转运体在调节腺苷的功能中起着至关重要的作用。本研究旨在探讨在模拟缺血条件下,核苷转运蛋白 4(ENT4)对心肌细胞中腺苷转运的贡献,以及抑制 ENT4 是否可以保护心肌细胞免受缺血再灌注损伤。

方法

使用 AC16 人心肌细胞建立模拟缺血/再灌注损伤的模型。用 decynium-22 或针对 ENT4 的特异性 siRNA 抑制 ENT4 的活性。通过 Western blot 分析测定核苷转运蛋白的蛋白表达。通过[?H]腺苷摄取研究转运活性。通过生化测定研究细胞损伤。

结果

AC16 细胞中的[?H]腺苷摄取主要由 ENTs 介导。ENT1 至 ENT4 存在于 AC16 细胞中,其蛋白表达水平在正常和缺血条件下相似。在正常条件下,decynium-22 或针对 ENT4 的 siRNA 并不影响 AC16 细胞中的腺苷摄取,但在缺血条件下可抑制 AC16 细胞中的腺苷摄取 28%。此外,decynium-22 或针对 ENT4 的 siRNA 可降低缺血条件下 AC16 细胞的细胞活力和乳酸脱氢酶释放。

结论

细胞培养模型表明,在缺血条件下,ENT4 可能在心肌细胞中腺苷转运中发挥作用。抑制或下调 ENT4 可能是一种潜在的心脏保护方法,但这一观点需要进一步通过动物模型进行验证。

相似文献

1
Contribution of ENT4 to adenosine uptake in AC16 human cardiomyocytes under simulated ischemic conditions and its potential role in cardioprotection.在模拟缺血条件下 ENT4 对 AC16 人心肌细胞中腺苷摄取的贡献及其在心脏保护中的潜在作用。
Mol Biol Rep. 2022 Nov;49(11):11201-11208. doi: 10.1007/s11033-022-07902-3. Epub 2022 Sep 15.
2
Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?平衡核苷转运体1和4:哪一个是抗缺血再灌注损伤心脏保护的更佳靶点?
J Cardiovasc Pharmacol. 2015 Jun;65(6):517-21. doi: 10.1097/FJC.0000000000000194.
3
Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.平衡核苷转运蛋白 1 在心脏保护中发挥着重要作用。
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H771-7. doi: 10.1152/ajpheart.00711.2009. Epub 2009 Dec 24.
4
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.平衡核苷转运体-4的分布与功能特性,一种在酸性pH下被激活的新型心脏腺苷转运体。
Circ Res. 2006 Sep 1;99(5):510-9. doi: 10.1161/01.RES.0000238359.18495.42. Epub 2006 Jul 27.
5
Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling.靶向心肌摄取核苷转运蛋白 ENT1 通过增强髓系腺苷 A2b 信号转导提供心脏保护。
JCI Insight. 2023 Jun 8;8(11):e166011. doi: 10.1172/jci.insight.166011.
6
USP49 inhibits ischemia-reperfusion-induced cell viability suppression and apoptosis in human AC16 cardiomyocytes through DUSP1-JNK1/2 signaling.USP49 通过 DUSP1-JNK1/2 信号通路抑制缺血再灌注诱导的人 AC16 心肌细胞活力抑制和凋亡。
J Cell Physiol. 2019 May;234(5):6529-6538. doi: 10.1002/jcp.27390. Epub 2018 Sep 24.
7
Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge.ENT1 敲除小鼠中不存在平衡核苷转运蛋白 1,导致缺氧应激后核苷水平改变。
Life Sci. 2011 Oct 24;89(17-18):621-30. doi: 10.1016/j.lfs.2011.08.007. Epub 2011 Aug 17.
8
Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.平衡核苷转运蛋白(ENT)-1 依赖性细胞外腺苷升高可在肝缺血再灌注期间保护肝脏。
Hepatology. 2013 Nov;58(5):1766-78. doi: 10.1002/hep.26505. Epub 2013 Sep 24.
9
Malaria parasite type 4 equilibrative nucleoside transporters (ENT4) are purine transporters with distinct substrate specificity.疟原虫 4 型平衡核苷转运蛋白(ENT4)是具有独特底物特异性的嘌呤转运蛋白。
Biochem J. 2012 Sep 1;446(2):179-90. doi: 10.1042/BJ20112220.
10
The equilibrative nucleoside transporter family, SLC29.平衡核苷转运体家族,SLC29。
Pflugers Arch. 2004 Feb;447(5):735-43. doi: 10.1007/s00424-003-1103-2. Epub 2003 Jun 28.

本文引用的文献

1
Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype.系统转录组学和表型特征分析人类和鼠心肌细胞系及原代心肌细胞,揭示了其与成年人心肌表型存在严重局限性和低相似度。
J Mol Cell Cardiol. 2022 Apr;165:19-30. doi: 10.1016/j.yjmcc.2021.12.007. Epub 2021 Dec 24.
2
Metformin relieves H/R-induced cardiomyocyte injury through miR-19a/ACSL axis - possible therapeutic target for myocardial I/R injury.二甲双胍通过 miR-19a/ACSL 轴缓解 H/R 诱导的心肌细胞损伤 - 心肌 I/R 损伤的可能治疗靶点。
Toxicol Appl Pharmacol. 2021 Mar 1;414:115408. doi: 10.1016/j.taap.2021.115408. Epub 2021 Jan 19.
3
Deletion of murine slc29a4 modifies vascular responses to adenosine and 5-hydroxytryptamine in a sexually dimorphic manner.小鼠 slc29a4 的缺失以性别二态的方式修饰了对腺苷和 5-羟色胺的血管反应。
Physiol Rep. 2020 Mar;8(5):e14395. doi: 10.14814/phy2.14395.
4
Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH.通过平衡核苷转运蛋白 4(hENT4)双向转运 2-氯腺苷:在酸性 pH 值下存在变构动力学的证据。
Sci Rep. 2019 Sep 19;9(1):13555. doi: 10.1038/s41598-019-49929-w.
5
Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).双嘧达莫类似物作为平衡核苷转运体的药理学抑制剂。鉴定新型强效和选择性人嘧啶核苷转运蛋白 4(hENT4)的腺苷转运功能抑制剂。
Biochem Pharmacol. 2013 Dec 1;86(11):1531-40. doi: 10.1016/j.bcp.2013.08.063. Epub 2013 Sep 7.
6
Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure.SSRIs 类药物的心血管作用机制及其在心梗和心衰中的获益与风险。
Int Clin Psychopharmacol. 2013 May;28(3):145-55. doi: 10.1097/YIC.0b013e32835d735d.
7
Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.靶向敲除质膜单胺转运体(Slc29a4)基因的小鼠脉络丛中单胺和有机阳离子摄取受损。
J Biol Chem. 2013 Feb 1;288(5):3535-44. doi: 10.1074/jbc.M112.436972. Epub 2012 Dec 19.
8
Cell biology of ischemia/reperfusion injury.缺血/再灌注损伤的细胞生物学。
Int Rev Cell Mol Biol. 2012;298:229-317. doi: 10.1016/B978-0-12-394309-5.00006-7.
9
Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?腺苷受体介导的心脏保护:所有 4 种亚型都必需还是冗余?
J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):21-33. doi: 10.1177/1074248410396877. Epub 2011 Feb 18.
10
Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.通过质膜单胺转运体进行腺苷转运:再研究与有机阳离子的比较。
Drug Metab Dispos. 2010 Oct;38(10):1798-805. doi: 10.1124/dmd.110.032987. Epub 2010 Jun 30.